Investigational Drug Information for Norketotifen
✉ Email this page to a colleague
What is the development status for investigational drug Norketotifen?
Norketotifen is an investigational drug.
There have been 4 clinical trials for Norketotifen.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 14th 2020.
The most common disease conditions in clinical trials are Influenza, Human, Rhinitis, Allergic, and Rhinitis. The leading clinical trial sponsors are Emergo Therapeutics, Inc. and [disabled in preview].
There are five US patents protecting this investigational drug and one hundred and thirty international patents.
Summary for Norketotifen
| US Patents | 5 |
| International Patents | 130 |
| US Patent Applications | 79 |
| WIPO Patent Applications | 30 |
| Japanese Patent Applications | 16 |
| Clinical Trial Progress | Phase 2 (2020-12-14) |
| Vendors | 21 |
Recent Clinical Trials for Norketotifen
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness | Emergo Therapeutics, Inc. | Phase 2 |
| Norketotifen for the Treatment of Uncomplicated Influenza-like Illness | Emergo Therapeutics, Inc. | Phase 2 |
| Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis | Emergo Therapeutics, Inc. | Phase 2 |
Clinical Trial Summary for Norketotifen
Top disease conditions for Norketotifen
Top clinical trial sponsors for Norketotifen
US Patents for Norketotifen
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Norketotifen | ⤷ Try a Trial | Anti-allergy benzocycloheptathiophene derivatives | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd (Fujian, CN) | ⤷ Try a Trial |
| Norketotifen | ⤷ Try a Trial | Mast cell stabilizers for treatment of hypercytokinemia and viral infection | Emergo Therapeutics, Inc. (Chapel Hill, NC) | ⤷ Try a Trial |
| Norketotifen | ⤷ Try a Trial | Controlled-release ophthalmic vehicles | Insite Vision Incorporated (Alameda, CA) | ⤷ Try a Trial |
| Norketotifen | ⤷ Try a Trial | Methods for stabilizing oxidatively unstable compositions | Johnson & Johnson Vision Care, Inc. (Jacksonville, FL) | ⤷ Try a Trial |
| Norketotifen | ⤷ Try a Trial | Methods and ophthalmic devices used in the treatment of ocular allergies | Johnson & Johnson Vision Care, Inc. (Jacksonville, FL) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Norketotifen
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Norketotifen | China | CN103619839 | 2031-06-28 | ⤷ Try a Trial |
| Norketotifen | European Patent Office | EP2727919 | 2031-06-28 | ⤷ Try a Trial |
| Norketotifen | Japan | JP2014526438 | 2031-06-28 | ⤷ Try a Trial |
| Norketotifen | Japan | JP5978296 | 2031-06-28 | ⤷ Try a Trial |
| Norketotifen | World Intellectual Property Organization (WIPO) | WO2013000406 | 2031-06-28 | ⤷ Try a Trial |
| Norketotifen | Argentina | AR059928 | 2026-09-29 | ⤷ Try a Trial |
| Norketotifen | Australia | AU2007305205 | 2026-09-29 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
